AAP News Vol. 13 No. 11 November 1997, p. 21
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 Previous Article  |  Next Article 

PROS and NMA collaborate on study of polio immunizaton changes

A study of the impact of recent recommendations for widespread use of inactivated polio vaccine (IPV) on immunization rates and health supervision compliance is being conducted jointly by Pediatric Research in Office Settings (PROS), the AAP practice-based research network, and the Pediatric Section of the National Medical Association (NMA) — the 100-year-old African American physician organization. The study is funded by the National Immunization Program of the Centers for Disease Control and Prevention.